investor faqs

Show all


The Alder Biopharmaceuticals ticker is ALDR and it is traded on the NASDAQ.
May 8th, 2014
Get contact information including address and phone numbers, and view a map to our corporate headquarters in Bothell, Washington. 
Read bios for all of our directors online. 
Meet our management team and read their bios online.
Credit Suisse Securities (USA) LLC, Leerink Partners LLC, Wells Fargo Securities, LLC, and Sanford C. Bernstein & Co., LLC.
The CUSIP number for Alder Biopharmaceuticals’ common stock is 014339 105.
American Stock Transfer & Trust Company, LLC.
If your shares are held in your name, you must contact our transfer agent, American Stock Transfer & Trust Company, LLC. If your shares are held in your street name you must contact your broker to update your address.
Our fiscal year ends December 31st
PricewaterhouseCoopers LLP, 1420 Fifth Avenue, Suite 1900, Seattle, WA 98101, (206) 398-3000.
Cooley LLP, 1700 Seventh Avenue, Suite 1900, Seattle, WA 98101-1355, (206) 452-8700.
We do not currently offer a dividend reinvestment program. We intend to retain all future earnings to finance the growth and development of our business and do not anticipate paying any cash dividends to our stockholdres in the foreseeable future.
Alder Biopharmaceuticals does not currently have a direct stock purchase plan.
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at
You can contact Alder Biopharmaceuticals’ Investor Relations department at: 
Sarah McCabe
Stern Investor Relations, Inc.
(212) 362-1200